Preliminary Scientific Program
The scientific sessions will take place in Lisbon and will be live-streamed to the Virtual platform for on-line attendees.
Please be aware that all times in the scientific program are in WEST, UTC+1 (Lisbon, Portugal)
We invite you to browse the Preliminary Program below
Prior start of the main program | Introductory Session for young EWOG
12.00 – 13.00
Registration for the Symposium
13.00 – 15.00
SESSION I
SEVERE APLASTIC ANEMIA
Selected oral abstracts
Invited speakers
Phillip Scheinberg (São Paulo, Brazil)
Recent advances and long-term results of medical treatment of Acquired Aplastic Anemia
Brigitte Strahm (Freiburg, Germany)
Stem cell transplantation in SAA
Austin Kulasekararaj (London, UK)
Somatic mutations and dynamics of clonal hematopoiesis in Acquired Aplastic Anemia
15.00 – 15.30
COFFEE BREAK
15.30 – 17.30
SESSION II
JUVENILE MYELOMONOCYTIC LEUKEMIA (I)
Selected oral abstracts
Invited speakers
Eliot Stieglitz (San Francisco, USA)
Novel approaches targeting the RAS pathway in JMML
Christian Flotho (Freiburg, Germany)
Clonal architecture in JMML
17:30 – 18.00
Official opening of the symposium
08.30 – 09.30
Young EWOG welcome breakfast
09.30 – 10.30
SESSION III
JUVENILE MYELOMONOCYTIC LEUKEMIA (II)
Invited speaker
Charlotte Niemeyer (Freiburg, Germany)
How to design the next clinical study in JMML
10.30 – 12.00
SESSION IV
BONE MARROW FAILURE AND OTHER GERMLINE PREDISPOSITION
Selected oral abstracts
Invited speakers
Akiko Shimamura (Boston,USA)
Clonal hematopoiesis in Shwachman-Diamond syndrome: mechanism and clinical implications
Marcin Wlodarski (Memphis, USA)
Whole genome sequencing based platform for diagnosis and discovery of BMF/MDS specific genetic alterations
12.00 – 13.00
Poster session
13.00 – 13.45
Lunch
13:45 – 17:30
SESSION V
PATHOPHYSIOLOGY OF MYELODYSPLASTIC SYNDROME (MDS) AND ACUTE MYELOID LEUKEMIA (AML)
Invited speakers
Katherine R. Calvo (Bethesda, USA)
Implications of novel classification of myeloid neoplasms for childhood MDS
Henrik Hasle (Aarhus, Denmark)
What can we deduce from genetic classification of myeloid neoplasia for therapy in pediatrics?
Miriam Erlacher (Freiburg, Germany)
The new kid on the block: UBTF-TD
09:00 – 10.30
INNOVATIVE THERAPIES IN MYELODYSPLASTIC SYNDROME, ACUTE MYELOID LEUKEMIA AND JUVENILE MYELOMONOCYTIC LEUKEMIA
Selected oral abstracts
Invited speakers
Franco Locatelli (Rome, Italy)
Novel approaches of immune and cellular therapies for high risk pediatric myeloid malignancies
10.30 – 11.00
COFFEE BREAK
11.00 – 12.30
Barbara De Moerloose (Gent, Belgium)
Pathway-directed therapy approach in pediatric MDS and AML
12.30 – 13.00
Closing remarks and presentation of poster prizes
Conference Time
The Meeting will officially run on Western European Summer Time – WEST, UTC+1